The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Biogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts
Open accessAbstract
Summary: Tailored nanoparticles offer a novel approach to fight antibiotic‐resistant microorganisms. We analysed biogenic selenium nanoparticles (Se NP s) of bacterial origin to determine their antimicrobial activity against selected pathogens in their planktonic and biofilm states. Se NP s synthesized by Gram‐negative Stenotrophomonas maltophilia [Sm‐Se NP s(−)] and Gram‐positive Bacillus mycoides [Bm‐Se NP s(+)] were active at low minimum inhibitory concentrations against a number of clinical isolates of Pseudomonas aeruginosa but did not inhibit clinical isolates of the yeast species Candida albicans and C. parapsilosis . However, the Se NP s were able to inhibit biofilm formation and also to disaggregate the mature glycocalyx in both P. aeruginosa and Candida spp. The Sm‐Se NP s(−) and Bm‐Se NP s(+) both achieved much stronger antimicrobial effects than synthetic selenium nanoparticles (Ch‐Se NP s). Dendritic cells and fibroblasts exposed to Sm‐Se NP s(−), Bm‐Se NP s(+) and Ch‐Se NP s did not show any loss of cell viability, any increase in the release of reactive oxygen species or any significant increase in the secretion of pro‐inflammatory and immunostimulatory cytokines. Biogenic Se NP s therefore appear to be reliable candidates for safe medical applications, alone or in association with traditional antibiotics, to inhibit the growth of clinical isolates of P. aeruginosa or to facilitate the penetration of P. aeruginosa and Candida spp. biofilms by antimicrobial agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary Practices
Jorgensen, J. H., & Ferraro, M. J. (2009) · Clinical Infectious Diseases · doi:10.1086/647952 · Cited by 1,894
Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2
Gantner, B. N., Simmons, R. M., Canavera, S. J., Akira, S., & Underhill, D. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021787 · Cited by 1,643
Nanotechnology as a therapeutic tool to combat microbial resistance
Pelgrift, R. Y., & Friedman, A. J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.011 · Cited by 1,432
IL-12 family cytokines: immunological playmakers
Vignali, D. A. A., & Kuchroo, V. K. (2012) · Nature Immunology · doi:10.1038/ni.2366 · Cited by 1,297
Biosynthesis of Nanoparticles by Microorganisms and Their Applications
Li, X., Xu, H., Chen, Z.-S., & Chen, G. (2011) · Journal of Nanomaterials · doi:10.1155/2011/270974 · Cited by 1,133
Kostakioti, M., Hadjifrangiskou, M., & Hultgren, S. J. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a010306 · Cited by 999
Alternative Antimicrobial Approach: Nano-Antimicrobial Materials
Beyth, N., Houri-Haddad, Y., Domb, A., Khan, W., & Hazan, R. (2015) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2015/246012 · Cited by 837
Bacteria in Nanoparticle Synthesis: Current Status and Future Prospects
Iravani, S. (2014) · International Scholarly Research Notices · doi:10.1155/2014/359316 · Cited by 494
New Insights into the Biology of the Acute Phase Response
Suffredini, A. F., Fantuzzi, G., Badolato, R., Oppenheim, J. J., & O'Grady, N. P. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020563913045 · Cited by 391
The dissolution and biological effects of silver nanoparticles in biological media
Loza, K., Diendorf, J., Sengstock, C., Ruiz-Gonzalez, L., Gonzalez-Calbet, J. M., Vallet-Regi, M., Köller, M., & Epple, M. (2014) · Journal of Materials Chemistry B · doi:10.1039/c3tb21569e · Cited by 372
Selenium nanoparticles inhibit Staphylococcus aureus growth
Webster, T. J., & Tran (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s21729 · Cited by 365
Antibiotic Discovery: Combatting Bacterial Resistance in Cells and in Biofilm Communities
Penesyan, A., Gillings, M., & Paulsen, I. (2015) · Molecules · doi:10.3390/molecules20045286 · Cited by 363
Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response
Grant, S. S., & Hung, D. T. (2013) · Virulence · doi:10.4161/viru.23987 · Cited by 363
Mechanisms of CNS response to systemic immune challenge: the febrile response
Elmquist, J. K., Scammell, H. E., & Saper, C. B. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01138-7 · Cited by 334
Effect of silver nanoparticles on Candida albicans biofilms: an ultrastructural study
Lara, H. H., Romero-Urbina, D. G., Pierce, C., Lopez-Ribot, J. L., Arellano-Jiménez, M. J., & Jose-Yacaman, M. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0147-8 · Cited by 323
Antibiotic Adjuvants: Diverse Strategies for Controlling Drug‐Resistant Pathogens
Gill, E. E., Franco, O. L., & Hancock, R. E. W. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12478 · Cited by 319
Ciofu, O., Tolker-Nielsen, T., Jensen, P. Ø., Wang, H., & Høiby, N. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.11.017 · Cited by 306
Wang, T., Yang, L., Zhang, B., & Liu, J. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2010.05.041 · Cited by 281
Evidence on the size-dependent absorption spectral evolution of selenium nanoparticles
Lin, Z.-H., & Chris Wang, C. R. (2005) · Materials Chemistry and Physics · doi:10.1016/j.matchemphys.2005.02.023 · Cited by 279
Shakibaie, M., Forootanfar, H., Golkari, Y., Mohammadi-Khorsand, T., & Shakibaie, M. R. (2015) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.07.020 · Cited by 277
Zonaro, E., Lampis, S., Turner, R. J., Qazi, S. J. S., & Vallini, G. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00584 · Cited by 252
Self-citationLampis, S., Zonaro, E., Bertolini, C., Cecconi, D., Monti, F., Micaroni, M., Turner, R. J., Butler, C. S., & Vallini, G. (2017) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2016.02.035 · Cited by 207
Self-citationLampis, S., Zonaro, E., Bertolini, C., Bernardi, P., Butler, C. S., & Vallini, G. (2014) · Microbial Cell Factories · doi:10.1186/1475-2859-13-35 · Cited by 193
Self-citationDrugs and autoimmunity – A contemporary review and mechanistic approach
Chang, C., & Gershwin, M. E. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.11.012 · Cited by 167
Synergy of Silver Nanoparticles and Aztreonam against Pseudomonas aeruginosa PAO1 Biofilms
Habash, M., Park, A. J., Vis, E. C., Harris, R. J., & Khursigara, C. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03170-14 · Cited by 150
Facile and controllable one-step fabrication of selenium nanoparticles assisted by l-cysteine
Li, Q., Chen, T., Yang, F., Liu, J., & Zheng, W. (2009) · Materials Letters · doi:10.1016/j.matlet.2009.12.019 · Cited by 126
Toll Receptor-Mediated Regulation of NADPH Oxidase in Human Dendritic Cells
Vulcano, M., Dusi, S., Lissandrini, D., Badolato, R., Mazzi, P., Riboldi, E., Borroni, E., Calleri, A., Donini, M., Plebani, A., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5749 · Cited by 124
Self-citationZenaro, E., Donini, M., & Dusi, S. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0409242 · Cited by 114
Self-citationGregorio, S. D., Lampis, S., & Vallini, G. (2004) · Environment International · doi:10.1016/j.envint.2004.09.021 · Cited by 106
Self-citationCentral role of dendritic cells in the regulation and deregulation of immune responses
Granucci, F., Zanoni, I., & Ricciardi‐Castagnoli, P. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8009-2 · Cited by 104
Immunotoxicity of Nanoparticles
Petrarca, C., Mangifesta, R., & Giampaolo, L. D. (2020) · Current topics in environmental health and preventive medicine · doi:10.1007/978-981-15-4735-5_6 · Cited by 98
Chudobová, D., Číhalová, K., Dostálová, S., Ruttkay-Nedecký, B., Rodrigo, M. Á. M., Tmejová, K., Kopel, P., Nejdl, L., Kudr, J., Gumulec, J., et al. (2013) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12353 · Cited by 81
Donini, M., Zenaro, E., Tamassia, N., & Dusi, S. (2007) · European Journal of Immunology · doi:10.1002/eji.200636532 · Cited by 67
Self-citationDendritic cells – why can they help and hurt us
Schäkel, K. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00823.x · Cited by 46
Admyre, C., Axelsson, L., von Stein, O. D., & Zargari, A. (2014) · Immunology · doi:10.1111/imm.12368 · Cited by 17
Cited by
Piacenza, E., Presentato, A., Ambrosi, E., Speghini, A., Turner, R. J., Vallini, G., & Lampis, S. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03178 · Cited by 959
Self-citationNano-selenium and its nanomedicine applications: a critical review
Hosnedlova, B., Kepinska, M., Skalickova, S., Fernandez, C., Ruttkay-Nedecky, B., Peng, Q., Baron, M., Melcova, M., Opatrilova, R., Zidkova, J., et al. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s157541 · Cited by 630
Singh, A., Gautam, P. K., Verma, A., Singh, V., Shivapriya, P. M., Shivalkar, S., Sahoo, A. K., & Samanta, S. K. (2020) · Biotechnology Reports · doi:10.1016/j.btre.2020.e00427 · Cited by 604
Ferro, C., Florindo, H. F., & Santos, H. A. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100598 · Cited by 442
Nanoparticles as antimicrobial and antiviral agents: A literature-based perspective study
Sharmin, S., Rahaman, M. M., Sarkar, C., Atolani, O., Islam, M. T., & Adeyemi, O. S. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06456 · Cited by 338
Metadata
- Authors
- Cremonini, E., Zonaro, E., Donini, M., Lampis, S., Boaretti, M., Dusi, S., Melotti, P., Lleo, M. M., & Vallini, G.
- Venue
- Microbial Biotechnology
- Publisher
- Wiley
- Published
- 2016-06-20
- Volume
- 9
- Issue
- 6
- Pages
- 758-771
- ISSN
- 1751-7915 (ISSN-L)
- OpenAlex
- W2464270559
- Cited by
- 261
- References
- 36
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.